A quick comment from Aiforia: we have not lost any clinical customers. In some cases, usage has started more slowly than expected, due to reasons such as the slow installation of laboratory systems and/or delays in scanner procurement. Won deals are recognized based on usage, and these new customer relationships from the past few months will start to show in revenue from 2H26 onwards. We have, of course, made adjustments on the sales and marketing side – for example, the recruitment of new salespeople is underway (UK, DACH, and Nordics), and channel activities have been streamlined. The market fundamentals have not changed – there is a need, and Aiforia’s product portfolio is competitive.